Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 69

    Indoco Remedies successfully clears USFDA inspection of CRO facility AnaCipher

    Indoco Remedies successfully clears USFDA inspection of CRO facility AnaCipher

    Medical Dialogues Bureau19 Oct 2019 11:05 AM IST
    Commenting on this development, Aditi Kare Panandikar, Managing Director, Indoco Remedies Limited said, “This achievement is for the fifth time in a...
    Merck gets European nod for Ebola vaccine Ervebo

    Merck gets European nod for Ebola vaccine Ervebo

    Medical Dialogues Bureau19 Oct 2019 9:15 AM IST
    The European Medicines Agency (EMA) said its human medicines committee (CHMP) has recommended granting conditional marketing authorization in the...
    Eli Lilly pancreatic cancer drug Pegilodecakin fails to meet endpoint

    Eli Lilly pancreatic cancer drug Pegilodecakin fails to meet endpoint

    Medical Dialogues Bureau19 Oct 2019 9:00 AM IST
    New Delhi: Eli Lilly and Company recently announced top-line results from its Phase 3 SEQUOIA trial evaluating pegilodecakin plus FOLFOX (folinic...
    Glenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg

    Glenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg

    Medical Dialogues Bureau18 Oct 2019 1:40 PM IST
    MUMBAI -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA)...
    USFDA red flag to Torrent Pharmas Indrad facility

    USFDA red flag to Torrent Pharma's Indrad facility

    Medical Dialogues Bureau18 Oct 2019 1:15 PM IST
    New Delhi: The US health regulator has red-flagged Torrent Pharmaceuticals for significant violations of current good manufacturing practice (CGMP)...
    Roche bags FDA approval of Xofluza (baloxavir marboxil) for treatment of acute, uncomplicated influenza

    Roche bags FDA approval of Xofluza (baloxavir marboxil) for treatment of acute, uncomplicated influenza

    Medical Dialogues Bureau18 Oct 2019 12:28 PM IST
    US: Roche today announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for XofluzaTM...
    Tevas UK arm recalls some batches of Ranitidine: Medicines watchdog

    Teva's UK arm recalls some batches of Ranitidine: Medicines watchdog

    Medical Dialogues Bureau18 Oct 2019 9:14 AM IST
    Teva Pharmaceutical’s UK unit has recalled some batches of heartburn medicine Ranitidine, Britain’s medicines watchdog said on Thursday, making it the...
    USFDA red flags Glenmark over batch failure investigations at Baddi facility

    USFDA red flags Glenmark over batch failure investigations at Baddi facility

    Medical Dialogues Bureau17 Oct 2019 1:28 PM IST
    New Delhi: The US health regulator has red flagged Glenmark Pharmaceuticals for failing to thoroughly investigate violation of manufacturing norms and...
    Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties

    Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties

    Medical Dialogues Bureau17 Oct 2019 1:14 PM IST
    New Delhi: Sun Pharmaceutical Industries recently announced that one of its wholly-owned subsidiaries has launched Drizalma Sprinkle™ (duloxetine...
    Fujifilm Max Healthcare to jointly train doctors in breast cancer detection

    Fujifilm Max Healthcare to jointly train doctors in breast cancer detection

    Medical Dialogues Bureau17 Oct 2019 9:28 AM IST
    New Delhi: Max Healthcare super speciality hospital in the National Capital on Tuesday signed a partnership with Japan's Fujifilm to train doctors in...
    USFDA rebukes Torrent Pharma management of inadequacy, violations at multiple sites

    USFDA rebukes Torrent Pharma management of inadequacy, violations at multiple sites

    Farhat Nasim16 Oct 2019 6:20 PM IST
    Repeated failures at multiple sites of Torrent Pharma demonstrate that executive management oversight and control over the manufacture of drugs is...
    JnJ cancer drugs Darzalex, Imbruvica help it beat profit estimates for third-quarter

    JnJ cancer drugs Darzalex, Imbruvica help it beat profit estimates for third-quarter

    Medical Dialogues Bureau16 Oct 2019 10:00 AM IST
    JnJ is facing more than 13,000 lawsuits tied to anti-psychotic drug Risperdal as well as a range of lawsuits involving its baby powder, opioids,...
    PrevNext

    Popular Stories

    Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO

    Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

    Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok